Skip to main content
Clinical Trials/NCT02874963
NCT02874963
Unknown
Not Applicable

Impact of Combined Non-surgical and Surgical Periodontal Treatment in Patients With Type 2 Diabetes Mellitus

University Clinical Centre of Kosova1 site in 1 country160 target enrollmentNovember 2015

Overview

Phase
Not Applicable
Intervention
Surgical Periodontal Treatment
Conditions
Periodontitis
Sponsor
University Clinical Centre of Kosova
Enrollment
160
Locations
1
Primary Endpoint
Biochemical parameter: HbA1c (mean value in %),
Last Updated
9 years ago

Overview

Brief Summary

This intervention study is designed to evaluate the effects of non-surgical procedure in addition to surgical procedure on systemic inflammation and glycemic control in with type 2 diabetes mellitus patients with periodontitis in comparison with non-diabetic periodontic patients.

Detailed Description

In a randomize, prospective study 200 patients from the endocrinology department of "Peja's Regional Hospital" and Dental Polyclinic at city of Peja, will be assessed and examined for eligibility. Personal interviews will be used to collect the baseline data from each participant using a pre structured questionnaire. After clinical examination, 160 patients aged 30-70 years will be selected for the study. These will be further divided in four groups: type 2 diabetes mellitus group (with or without initial periodontal therapy) and non-diabetic group (with or without initial periodontal therapy). All the patients will be with periodontal disease and at least one tooth extraction will perform. Previous to surgery procedures, in particular in the two groups with an adjunctive non surgical periodontal treatment such as full mouth tooth cleaning will be included: full-mouth scaling and root planing (FM-SRP) with ultrasonic device (UDS-J Ultrasonic Scaler, Guilin Woodpecker Medical Instrument) and periodontal curets for mechanical debridement of the supra- and sub-gingival plaque and calculus. Post operative rinsing will be followed with antiseptic solution Listerine® (ethanol 21.6%, methyl salicylate 0.06%, menthol 0.042%, thymol 0.064% and eucalyptol 0.092%) as a mouthwash thrice a day for 3 weeks.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
October 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Clinical Centre of Kosova
Responsible Party
Principal Investigator
Principal Investigator

Dashor Bukleta

Oral Surgery Specialist (PhD Candidate)

University Clinical Centre of Kosova

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with type 2 Diabetes Mellitus; having a baseline HbA1c ≥ 6.5%, at least 10 teeth in the functional dentition (excluding third molars) and a clinical diagnosis of periodontal disease with at least one site with probing depth (PD) ≥ 5mm, and two teeth with attachment lost ≥ 6mm and no modification in the pharmacological treatment of diabetes during the study period.

Exclusion Criteria

  • Pregnancy or lactation, major diabetic complications, uses of antibiotic therapy or non-steroidal anti-inflammatory drug therapy 4 months before the first visit.

Arms & Interventions

Surgical periodontal treatment

Type 2 Diabetes Patients with periodontitis (without initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Non-Diabetes Patients with periodontitis (without initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Intervention: Procedure: Surgery (Tooth Extraction)

Intervention: Surgical Periodontal Treatment

Surgical and non-surgical periodontal treatment

Type 2 Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Non-Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Interventions: Procedure: Surgery (Tooth Extraction) Procedure: Non-surgical periodontal therapy-full mouth scaling and root planing (FM-SRP) with ultrasonic device and periodontal curets for mechanical debridement of the supra- and sub-gingival plaque and calculus, post operative rinsing thrice a day for 3 weeks.

Intervention: Surgical Periodontal Treatment

Surgical and non-surgical periodontal treatment

Type 2 Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Non-Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Interventions: Procedure: Surgery (Tooth Extraction) Procedure: Non-surgical periodontal therapy-full mouth scaling and root planing (FM-SRP) with ultrasonic device and periodontal curets for mechanical debridement of the supra- and sub-gingival plaque and calculus, post operative rinsing thrice a day for 3 weeks.

Intervention: Non Surgical Periodontal Treatment includes scaling root planing with UDS-J Ultrasonic Scaler.

Surgical and non-surgical periodontal treatment

Type 2 Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Non-Diabetes Patients with periodontitis (with initial non-surgical periodontal therapy) at least one tooth extraction will be performed. Interventions: Procedure: Surgery (Tooth Extraction) Procedure: Non-surgical periodontal therapy-full mouth scaling and root planing (FM-SRP) with ultrasonic device and periodontal curets for mechanical debridement of the supra- and sub-gingival plaque and calculus, post operative rinsing thrice a day for 3 weeks.

Intervention: Non Surgical Periodontal Treatment includes post operative mouth wash with Listerine® (ethanol 21.6%, methyl salicylate 0.06%, menthol 0.042%, thymol 0.064% and eucalyptol 0.092%)

Outcomes

Primary Outcomes

Biochemical parameter: HbA1c (mean value in %),

Time Frame: Baseline and 3 months after

The changes in levels of glycated haemoglobin after periodontal treatment.

Biochemical parameter: high sensitive C-Reactive Protein - hs-CRP (mean value in mg/L)

Time Frame: Baseline and 3 months after

The changes in levels of c-reactive protein after periodontal treatment.

Secondary Outcomes

  • Bleeding on probing (BOP) (expressed in %)(Baseline and 3 months after)
  • Mean attachment level (MAL) (mean in mm, as a measure of periodontal parameter)(Baseline and 3 months after)
  • Plaque index (PI) (expressed in %)(Baseline and 3 months after)
  • Mean probing depth (PD) (mean in mm, as a measure of periodontal parameter)(Baseline and 3 months after)

Study Sites (1)

Loading locations...

Similar Trials